Physician profile
Christopher N Bui
NPI 1619231537
$16,009.86
in general payments reported to CMS, 2019-2025
5 companies · $5,365 in 2025
The $5,365 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,949 · 2020: $45.28 · 2021: $2,006 · 2022: $570 · 2023: $1,017 · 2024: $1,057 · 2025: $5,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,520 · Travel and Lodging: $1,919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,520.45 |
| Travel and Lodging | $1,918.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $15,718.67 | 2019-2025 | Gamma, Pangea, Pro |
| Astrazeneca Pharmaceuticals LP | $121.37 | 2025 | Airsupra |
| Nestle Healthcare Nutrition INC. | $102.20 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.25 | 2021 | |
| Axogen | $29.37 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.